Manufacturing and Capabilities
Subscribe to Manufacturing and Capabilities

The Lead

Valeant Pharmaceuticals Completes Acquisition Of Salix Pharmaceuticals

April 1, 2015 12:28 pm | by Valeant Pharmaceuticals International | News | Comments

Valeant Pharmaceuticals International today announced it has completed the previously announced acquisition of Salix Pharmaceuticals.

HHS Contracts to Develop New Ebola Drug

March 31, 2015 11:54 am | by U.S. Department of Health & Human Services | News | Comments

HHS awarded approximately $12 million today to BioCryst Pharmaceuticals of Durham, North...

Teva Launches Exforge Generic

March 31, 2015 11:33 am | News | Comments

Teva announces the launch of the generic equivalent to Exforge (amlodipine and valsartan)...

Recipharm and Adroit Science Form Collaboration to Expand Service Offering

March 26, 2015 3:53 pm | News | Comments

Recipharm AB and Adroit Science AB have announced the formation of a new strategic collaboration...

View Sample

FREE Email Newsletter

Genentech Announces Plans to Expand Hillsboro Facility

March 26, 2015 3:26 pm | News | Comments

Genentech, a member of the Roche Group, has announced plans to invest more than $125 million for the expansion of its fill/finish facility in Hillsboro, Oregon.

Shire and Cincinnati Children's Establish Rare Disease Research Collaboration

March 26, 2015 8:17 am | News | Comments

The goal of the collaboration is to discover and develop novel therapies to treat rare diseases with high unmet medical need combining Shire's development and commercialization capabilities with Cincinnati Children's research expertise.

Capsugel Investing More Than $25M in Increased Production Capacity and Quality Enhancements

March 26, 2015 7:59 am | News | Comments

Capsugel has announced that the company is investing more than $25 million to increase production capacity and deliver further quality enhancements for its vegetarian capsules.


AstraZeneca to Collaborate With the Harvard Stem Cell Institute in Diabetes

March 25, 2015 8:45 am | News | Comments

AstraZeneca has entered into a five-year research collaboration with the Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells for use in screens of AstraZeneca’s compound library in the search for new treatments for diabetes.

Managing the SUS-Based Facility Design

March 25, 2015 8:31 am | by Jeff Odum, CPIP, IPS-Integrated Project Services, Inc. | Blogs | Comments

There are many nuances that require a more focused approach to risk identification and project management for the “new” manufacturing facilities implementing Single-use Systems (SUS). 

Sun Pharma Announces Closure of Merger Deal with Ranbaxy

March 25, 2015 8:11 am | News | Comments

Sun Pharma today, begins the integration of Ranbaxy's business following the successful closure of its merger.  The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.

Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab

March 23, 2015 8:07 am | News | Comments

Pfizer and Eli Lilly announced today that they are preparing to resume the Phase 3 clinical program for tanezumab. As a result, Pfizer expects to receive a $200 million upfront payment from Lilly in accordance with their collaboration agreement.

Coronado Biosciences Announces the Formation of Mustang Therapeutics

March 20, 2015 8:17 am | News | Comments

Coronado Biosciences has announced the formation of a new company, Mustang Therapeutics, Inc. Mustang will initially focus on the preclinical and clinical development, as well as commercialization of proprietary Chimeric Antigen Receptor (CAR-T) technology.


Evotec and Sanofi Sign Agreement for Major Multi-Component Strategic Alliance

March 20, 2015 8:05 am | News | Comments

Evotec AG today announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been signed with Sanofi. The transaction is expected to close on 31 March 2015.

AbbVie and Puerto Rico Announce $30M Expansion

March 18, 2015 1:40 pm | News | Comments

Puerto Rico and AbbVie announced today the expansion of one of AbbVie’s existing sites in the island with an estimated investment of $30M. This expansion will add to Puerto Rico’s capabilities as a manufacturing destination for biotechnology and is expected to create up to 100 new jobs over the next two years.

Xcelience Receives DEA Approval to Develop and Manufacture DEA Schedule I Drug Products

March 17, 2015 2:56 pm | News | Comments

Xcelience has received approval from the Federal Drug Enforcement AdminIstration to develop and manufacture Schedule I controlled substances in their facilities. Schedule I substances are "considered the most dangerous class of drugs," according to the DEA website. 

Phase III Study with IMBRUVICA Combination Demonstrates Significant Delay in Disease Progression

March 17, 2015 8:45 am | News | Comments

Janssen has announced that a pre-planned interim analysis of the Phase 3 HELIOS study investigating the combination of IMBRUVICA plus bendamustine and rituximab (BR) versus placebo plus BR in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, showed the trial has met its primary endpoint.

Galapagos Regains Rights to GLPG1690, Ends Alliance with Janssen

March 17, 2015 8:29 am | News | Comments

Galapagos NV has announced that Janssen Pharmaceutica NV and Galapagos have mutually agreed to terminate the inflammation alliance and option agreements between the companies.


Johnson Matthey Commissions New High Containment Manufacturing Capacity in Edinburgh, UK

March 13, 2015 2:06 pm | News | Comments

Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion and commissioning of new high containment facilities for potent product manufacture at its Edinburgh, UK site (Macfarlan Smith).

Xcelience to Expand Headquarter Operations in Tampa

March 13, 2015 1:12 pm | News | Comments

Florida's Governor Rick Scott announced the expansion of Xcelience, an international contract development and manufacturing organization (CDMO) servicing the pharmaceutical and biotechnology industries. Xcelience will expand product development services and manufacturing operations in Tampa, creating 100 new jobs and retaining another 100 jobs. Xcelience will also invest $9M in the region as part of the expansion.

Klöckner Pentaplast Group and Berry Plastics Group Form Marketing Alliance

March 13, 2015 8:03 am | News | Comments

Berry Plastics Group, Inc. and Klöckner Pentaplast Group, announced that the companies recently entered into a marketing alliance to offer innovative form-fill seal packaging solutions, on a global basis to the food, consumer, pharmaceutical, and medical markets.

Genetic Test Maker 23andMe Launches Drug R&D Effort

March 12, 2015 8:11 am | by MATTHEW PERRONE, AP Health Writer | News | Comments

Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.

Particle Sciences to Expand Sterile Manufacturing for Complex Products and Particulates

March 10, 2015 8:37 am | News | Comments

Particle Sciences, Inc. is expanding its sterile and aseptic manufacturing capacity generally and specifically for nano-milled drug products.

Report: Reshoring to Boost Industrial Construction in 2015

March 9, 2015 8:30 am | by Andy Szal, Digital Reporter | News | Comments

Construction research firm CMD expects starts of industrial construction projects to increase 7.8 percent this year due in large part to reshoring efforts by U.S. manufacturers.

Study: U.S. Biosimilar Approvals Poised to Grow, But Market Uptake Faces Several Challenges

March 5, 2015 3:32 pm | News | Comments

Biosimilar approvals in the United States are expected to increase during the next five years, but safety concerns among physicians and the need for greater regulatory clarity concerning therapeutic interchangeability could hinder market uptake, according to a study recently completed by the Tufts Center for the Study of Drug Development.

UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets

March 4, 2015 11:14 pm | News | Comments

UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Sprout Pharmaceuticals to manufacture Flibanserin 100 mg tablets.

Johnson & Johnson Innovation Announces New Startup Campus

March 3, 2015 2:17 pm | by Andy Szal, Digital Reporter | News | Comments

The venture capital arm of the New Jersey consumer products giant officially unveiled its JLABS@South San Francisco campus Monday. The 30,000-square foot incubator will eventually house up to 50 startups.

Blueprint Medicines Announces $265M Strategic Collaboration with Alexion

March 3, 2015 1:48 pm | News | Comments

Blueprint Medicines has announced a strategic collaboration with Alexion to discover, develop and commercialize novel drug candidates for an undisclosed activated kinase target, which is the cause of a rare genetic disease.

Catalent Expands European Clinical Packaging Capabilities

February 26, 2015 3:01 pm | News | Comments

Catalent Pharma Solutions has announced several expanded capabilities within its European Clinical Supply Services network. The expansions have been implemented in response to increased customer demand for specialty clinical packaging, where the proportion of highly-potent or temperature-sensitive investigational medical products continues to increase.

Huntingdon Life Sciences and Harlan Laboratories to Operate Under New Brand and Name

February 24, 2015 11:11 am | News | Comments

Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined organizations.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.